Drug Markets/Anakinra

Anakinra

1 NDC across 1 manufacturer|0 Generic,1 Brand

Anakinra is used to treat rheumatoid arthritis and cryopyrin-associated periodic syndromes, per the National Library of Medicine's MED-RT classification.

▸ More about this market

In 2024, Medicare Part D spent $32 million on Anakinra across 5,321 claims for 921 beneficiaries.

Anakinra is available as 1 NDC from 1 manufacturer (0 generic, 1 brand), with NADAC prices from $192.31 to $192.31 per ML. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

1

0G / 1B

Manufacturers

1

competing in market

Price Spread

$192.31 – $192.31

per ML

7d Activity

1 flat

avg +0.0% WoW · of 1 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Explore this market from other angles

Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.

Manufacturer Breakdown

1 manufacturer producing ANAKINRA

Drug Portfolio

1 NDCs total, 1 shown

Drug ↕Price 7d Change ↕
KINERET 100 MG/0.67 ML SYRINGE
$192.3106
per ML
—

Frequently Asked Questions

What is Anakinra used to treat?

Anakinra is used to treat rheumatoid arthritis and cryopyrin-associated periodic syndromes, per the National Library of Medicine's MED-RT classification.

How much does Medicare spend on Anakinra?

In 2024, Medicare Part D spent $32 million on Anakinra across 5,321 claims for 921 beneficiaries.

How many Anakinra products are on the market?

The Anakinra drug market contains 1 NDC from 1 manufacturer — 0 generic and 1 brand product.

What is the price range for Anakinra?

NADAC reference prices for Anakinra range from $192.3106 to $192.3106 per ML.

Which manufacturers make Anakinra?

1 manufacturer lists Anakinra in NADAC. Ranked by number of NDCs, the largest are Swedish Orphan Biovitrum AB (publ) (1).